Abstract
A systematic review and meta-analysis were carried out involving studies that compared the nutritional complications of Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB); these included the incidence of malnutrition as well as deficiencies of other nutritional elements, such as total protein, albumin, calcium and iron. A comprehensive search strategy was implemented in PubMed, Embase, and the Cochrane Library. Effect sizes included the pooled odds ratios (ORs) and 95% confidence intervals (95% CIs), as well as mean differences (MDs) and 95% CIs of the percentage total weight loss (%TWL) and excess weight loss percentage (%EWL).
Thirteen studies were included (12,964 patients, 66.27% females, 53.82% underwent OAGB). At the longest follow-up period (≥3 years), OAGB was associated with significantly higher %TWL (MD=5.41%, 95%CI, 1.52 to 9.29) and %EWL (MD=13.81%, 95%CI, 9.60 to 18.02) compared to RYGB. However, OAGB procedures were associated with malnutrition (OR=3.00, 95%CI, 1.68 to 5.36, p<0.0001), hypoalbuminemia (OR=2.38, 95%CI, 1.65 to 3.43, p<0.0001), hypoproteinemia (OR=1.85, 95%CI, 1.09 to 3.14, p=0.022), anemia (OR=1.38, 95%CI, 1.08 to 1.77, p=0.011), and hypocalcemia (OR=1.78, 95%CI, 1.01 to 3.12, p=0.046). On subgroup analyses, the proportions of anemia and hypoalbuminemia remained significantly higher at longer follow-up periods and in studies published in Asia.
Despite the favorable weight loss profile, the unfavorable nutritional consequences of OAGB merits further investigations to explore the malabsorptive element, ethnic variation, and the role of biliopancreatic limb length.
Keywords: one-anastomosis gastric bypass, comparative, hypoalbuminemia, malnutrition, roux-en-y, gastric bypass
Introduction and background
Introduction
Obesity and its related comorbidities have become an important health priority due to their effects on life quality and expectancy. The prevalence of obesity has dramatically increased worldwide, with more than 650 million obese adults and 2.5 million obesity-related deaths as of 2016 [1]. With the projected increase in obesity prevalence over the next decades [2,3], it is necessary to adopt effective managemental approaches via lifestyle, medical and surgical interventions. In particular, bariatric surgery has proven effective to achieve adequate weight loss, particularly among patients with morbid obesity [4].
Roux-en-Y gastric bypass (RYGB) is a restrictive-malabsorptive procedure that is superior to non-surgical treatment in terms of weight loss outcomes and resolution of co-morbidities [5,6]. It was first introduced by Mason in 1966 [7] and the first laparoscopic procedure was performed in 1994 by Alan Wittgrove [8]. With the exponential increase in the number of bariatric surgeries since the early 2000s, RYGB has been considered the gold standard procedure for the management of morbidly obese patients [9]. The procedure involves creating a small gastric pouch connected to a roux limb (gastrojejunostomy) and an additional jejunojejunostomy is created at the level of the proximal jejunum. Laparoscopic RYGB is one of the most technically demanding laparoscopic techniques and requires appropriate surgical skills [10].
In 2001, Rutledge [11] proposed a modified, less technically-demanding technique, namely mini-gastric bypass, which was subsequently modified to one-anastomosis gastric bypass (OAGB) [12]. It consists of the formation of a gastrojejunal anastomosis between a long, narrow gastric pouch (restrictive part) and a jejunal omega loop (malabsorptive part) [13]. OAGB surgery has gained popularity over the past few years, and it has shown comparable efficacy and safety outcomes to those of the RYGB technique [14].
However, despite their clinical benefits, RYGB and OAGB procedures might be associated with a number of surgical and gastrointestinal complications, of which malabsorptive complications deserve considerable attention. These include anemia, deficiencies of vitamins and minerals, protein malnutrition, and abnormalities of bone metabolism [15,16]. Relevant data based on randomized clinical trials of nutritional deficiencies, and complications are scarce [17,18] and, to the best of our knowledge, no comprehensive systematic reviews have been conducted as yet to compare the nutritional outcomes of RYGB and OAGB. Considering the accumulated evidence so far, we conducted a systematic review and meta-analysis of studies that compared the nutritional complications of RYGB and OAGB.
Review
Methods
Eligibility Criteria
The present study was designated based on the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement [19]. Eligible studies should have compared the incidence of at least one postoperative nutritional complication at follow-up (at ≥ 1 year) after RYGB and OAGB procedures. RCTs, prospective cohort investigations, and retrospective studies written in English were eligible. Systematic reviews, narrative reviews, and case reports were excluded.
Types of Outcomes Measures
The primary outcomes included the frequencies of patients with nutritional complications at the most recent follow-up timepoint. These complications included anemia, hypoalbuminemia, hypocalcemia, hypoproteinemia, as well as serum deficiencies of vitamin D, vitamin B12, zinc, iron, and ferritin. Percentage total weight loss (%TWL) and excess weight loss (%EWL) at follow-up were considered secondary outcomes.
Search Strategy
The search strategy was carried out on three academic databases, including PubMed, Embase, and the Cochrane Library up to October 25, 2021. No limitations were set to the date of publication or study design. A relevant search strategy was developed using specific search terms, which were combined using the predefined Boolean operators (AND, OR, and NOT). An example of the used strategy is demonstrated in Appendix 1.
Study Selection and Data Collection
Screening of the obtained records across the academic databases was performed by two independent authors. A reference list was uploaded from each library to a dedicated software (EndNote X9, released 2013, Clarivate™, Philadelphia, Pennsylvania, United States) to detect and remove duplicate records. The bibliographies of screened articles were additionally searched for potentially eligible studies. The full-text versions of eligible articles were downloaded and checked against the inclusion/exclusion criteria. A specific spreadsheet was created on Microsoft Excel 2016 (Microsoft® Corp., Redmond, Washington, United States) for data collection. The extracted data included the following domains: (1) study characteristics, including the last name of the first author, study setting (country), date of publication, study design, and the latest follow-up timepoint; (2) patients’ characteristics at baseline, including the gender, age, body mass index; (3) procedural characteristics, including the number of patients who underwent RYGB and OAGB and the length of the alimentary (roux) limb in RYGB procedures and biliopancreatic limbs in RYGB and OAGB; (4) outcome variables: the frequencies of patients with nutritional complications. For the primary and secondary outcomes, data were collected from the most recent follow-up visit for each study.
Quality Assessment
The recommended Cochrane risk of bias tool [20] was used to assess the methodological quality of RCTs. Such a tool measures the risk of bias in selected quality indicators, including random sequence generation, allocation concealment, attrition bias, and blinding. Regarding non-randomized studies, the Newcastle-Ottawa Scale (NOS) [21] was utilized to explore the methodological quality in terms of participants’ selection, comparability, and outcomes. A NOS score was calculated by summing up the number of stars allocated to the selected items. Studies with a NOS score of 4-6 and ≥ 7 were considered of medium or high quality, respectively.
Statistical Analysis
The GetData™ Graph Digitizer version 2.26 (GetData Pty Ltd, Kogarah, New South Wales, Australia) was used to extract numerical outcomes from visually-depicted data. During data extraction, SDs were derived from confidence intervals (CIs) using the standard methods of the Cochrane handbook for systematic reviews of interventions [22]. In addition, means and SDs were estimated from the reported medians and interquartile ranges as described earlier [23]. The differences in frequencies of nutritional complications between RYGB and OAGB were analyzed by calculating the pooled odds ratios (ORs) and their respective 95%CIs. Furthermore, the pooled differences in %TWL and %EWL were estimated using mean differences (MDs) and 95%CIs. Statistical heterogeneity between studies was explored using an Identify and Interpret (I2) method, and it was considered statistically significant at I2>50%. Random-effects were applied on models with significant heterogeneity; otherwise, fixed-effects models were used. Subgroup analysis was performed based on sample size, study location, follow-up periods, and study design. Based on the sample size, studies were categorized into small (n< 500), medium (n = 500-1500) and large-sized studies. Assessment of publication bias was performed by producing funnel plots and interpreting the outcomes of Egger’s test. The meta-analysis was performed using the metacont and metabin packages in R (RStudio 2021.09.2+382, RStudio Corp., Boston, Massachusetts, United States).
Results
Results of the Search Process
Initially, we identified a total of 392 records across all databases, of which 23 duplicate records were excluded. Out of the remaining records (n=369), the full article version of 23 articles were thoroughly assessed for eligibility. However, 10 articles were excluded due to lack of primary outcomes [24-28], article retraction [29], short follow-up periods (six months) [30,31], lack of access to a full article [32], and an article published in a non-English language [33]. Therefore, 13 studies were formally included in our systematic review and meta-analysis (Figure 1).
Figure 1. Studies included in the systematic review and meta-analysis.
Characteristics of the Included Studies
Study-related characteristics are demonstrated in Table 1. Out of the included studies, there was one RCT [17], while the remaining studies employed a retrospective investigation of patients’ records. Eight studies were published in Asian countries [34-41], four studies in Europe [17,42-44], and one study in Australia [45]. Follow-up periods ranged between one and 15 years. Regarding patients’ characteristics, 12,964 patients were studied in the included articles, of whom 66.27% were females. Furthermore, 53.82% and 46.18% of patients had undergone OAGB and RYGB procedures, respectively. Other demographic characteristics of patients are listed in Table 2.
Table 1. Characteristics of the included studies.
N: number; Y: years; OAGB: one-anastomosis gastric bypass; BPL: biliopancreatic limb; RYGB : Reux-en-Y gastric bypass; NOS: Newcastle-Ottawa score; RCT: randomized controlled trial
| Author, year | Country | Study design | N of bariatric sites | Follow-up period (y) | Length of bowel segments (cm) | NOS | ||
| OAGB BPL | RYGB alimentary (roux) limb | RYGB BPL | ||||||
| Alkhalifah et al. 2018 [34]. | Taiwan | Retrospective | 1 | 15 | 150–250 | 150 | 100 | 7 |
| Baig et al. 2019 [35]. | India | Retrospective | 25 | 5 | 150-210 | 70-150 | 50-125 | 7 |
| Bhandari et al. 2019 [36]. | India | Retrospective | 1 | 5 | 250 | 120 | 80 | 7 |
| Chen et al. 2019 [37]. | Taiwan | Retrospective | 1 | 1 | 150-400 | 150-350 | 100 | 7 |
| Jammu et al. 2016 [38]. | India | Retrospective | 1 | 7 | 200 | 75-150 | 50 | 7 |
| Khalaj et al. 2020 [39]. | Iran | Retrospective | 1 | 1 | 200 | 150 | 50 | 7 |
| Lee et al. 2012 [40]. | Taiwan | Retrospective | 1 | 5 | 200 | 120 | 60 | 7 |
| Madhok et al. 2018 [42]. | UK | Retrospective, case matched | 1 | 2 | 200 | 150 | 50 | 7 |
| Rheinwalt et al. 2020 [43]. | Germany | Retrospective | 1 | 3 | 200-300 | 160 | 80 | 9 |
| Robert et al. 2019 [17]. | France | Open-label RCT (YOMEGA) | 9 | 2 | 200 | 150 | 50 | NA |
| Soheilipour et al. 2021 [41]. | Iran | Retrospective | 1 | 1 | NA | NA | NA | 7 |
| Voglino et al. 2021 [44]. | Italy | Retrospective, case matched | 1 | 3 | 200 | 150 | 80 | 7 |
| Zarshenas et al. 2021 [45]. | Australia | Retrospective | 1 | 2 | 200 | 100 | 100 | 7 |
Table 2. Patient characteristics at baseline.
N: number; M: male; F: female; OAGB: one-anastomosis gastric bypass; RYGB: Reux-en-Y gastric bypass; T: total number
| Author, year | N of patients | Gender (M/F) | Age, years (Mean ± SD) | BMI, kg/m2 (Mean ± SD) | |||
| OAGB/RYGB/T | OAGB | RYGB | OAGB | RYGB | OAGB | RYGB | |
| Alkhalifah et al. 2018 [34]. | 1731/805/2536 | 519/1212 | 232/573 | 33.80 ± 10.40 | 35.40 ± 10.10 | 40.40 ± 7.70 | 38.50 ± 6.50 |
| Baig et al. 2019 [35]. | 1194/2965/4159 | 548/646 | 1373/1592 | 43.07 ± 11.42 | 43.98 ± 11.65 | 45.08 ± 8.82 | 44.93 ± 7.91 |
| Bhandari et al. 2019 [36]. | 90/122/212 | 60/30 | 65/57 | 44.00 ± 10.90 | 46.40 ± 10.50 | 46.00 ± 6.90 | 42.00 ± 6.20 |
| Chen et al. 2019 [37]. | 1022/377/1399 | 326/696 | 109/268 | 34.40 ± 10.90 | 35.90 ± 10.60 | 41.20 ± 7.70 | 38.60 ± 6.70 |
| Jammu et al. 2016 [38]. | 473/295/768 | 140/333 | 85/210 | NA | NA | NA | NA |
| Khalaj et al. 2020 [39]. | 272/145/417 | 41/231 | 29/116 | 38.90 ± 10.70 | 40.20 ± 10.70 | 46.70 ± 6.40 | 44.50 ± 5.80 |
| Lee et al. 2012 [40]. | 1163/494/1657 | 313/850 | 132/362 | 32.30 ± 9.10 | 33.50 ± 9.30 | 41.10 ± 6.10 | 40.50 ± 5.80 |
| Madhok et al. 2018 [42]. | 200/200/400 | 61/139 | 61/139 | 45.00 ± 11.40 | 45.00 ± 11.00 | 49.00 ± 7.30 | 48.00 ± 6.70 |
| Rheinwalt et al. 2020 [43]. | 324/288/612 | 82/242 | 58/230 | 42.51 ± 11.36 | 41.40 ± 10.04 | 53.75 ± 6.51 | 44.53 ± 3.65 |
| Robert et al. 2019 [17]. | 117/117/234 | 32/85 | 26/91 | 44.40 ± 11.40 | 52.60 ± 10.20 | 43.80 ± 6.10 | 43.90 ± 5.10 |
| Soheilipour et al. 2021 [41]. | 289/94/383 | NA | NA | NA | NA | NA | NA |
| Voglino et al. 2021 [44]. | 57/57/114 | 12/45 | 11/46 | 41.00 ± 9.89 | 41.00 ± 8.37 | 46.30 ± 6.85 | 46.80 ± 5.55 |
| Zarshenas et al. 2021 [45]. | 45/28/73 | 13/32 | 6/22 | 52.70 ± 11.30 | 50.50 ± 9.50 | 47.10 ± 8.00 | 42.50 ± 7.30 |
Regarding the results of quality assessment, retrospective studies had generally high methodological quality (NOS ranged between seven and nine, Table 1). Patient selection was appropriate since patients in both surgical groups were selected from the same population (obese patients), and their data were retrieved from secure hospital records. The authors in only one study have adjusted the analyses for age and other demographic characteristics [43]. Concerning the included RCT [17], selection bias was judged as “low risk” because group randomization was performed using a computer-generated sequence, and patients were allocated using sealed envelopes. However, there was a high risk of performance bias since the blinding of the participants and study personnel was not possible (open-label) due to procedural differences. The risks of attrition bias (incomplete outcome data) and reporting bias (selective reporting) were considered “low” because all the outcomes were adequately reported with no potential effects on the results due to withdrawals.
Weight Loss
At one year of follow-up, patients in the OAGB arm had attained significantly higher %EWL than those in the RYGB arm (MD = 3.70%, 95%CI, 2.54 to 4.86) with no between-group differences in %TWL. However, at ≥ 3 years (the latest follow-up time point), the %TWL and %EWL were significantly higher after OAGB compared to RYGB (MD = 5.41%, 95%CI, 1.52 to 9.29 for %TWL and MD = 13.81%, 95%CI, 9.60 to 18.02 for %EWL, Figure 2).
Figure 2. Weight loss differences between OAGB and RYGB.
OAGB: one-anastomosis gastric bypass; RYGB: Reux-en-Y gastric bypass
Primary Outcomes
Table 3 demonstrates a summary of the primary outcomes. In general, malnutrition was significantly associated with OAGB procedures (OR = 3.00, 95%CI, 1.68 to 5.36, p < 0.0001). Robert et al. [17]. have defined malnutrition as albumin concentration of <30 g/L or prealbumin concentration of <0.2 g/L or both, whereas malnutrition was considered as deficiency of total protein, albumin, calcium, iron, or vitamins in the study of Rheinwalt et al. [43]. OAGB procedures were also associated with significantly higher odds of hypoalbuminemia (OR = 2.38, 95%CI, 1.65 to 3.43, p < 0.0001), hypoproteinemia (OR = 1.85, 95%CI, 1.09 to 3.14, p = 0.022), anemia (OR = 1.38, 95%CI, 1.08 to 1.77, p = 0.011), and hypocalcemia (OR = 1.78, 95%CI, 1.01 to 3.12, p = 0.046). Such significant associations were based on pairwise comparisons with no significant heterogeneity (I2 = 0-31%). The odds of vitamin D and vitamin B12 deficiencies, as well as the deficiencies of iron, ferritin, and zinc, were not significantly different between both the laparoscopic procedures.
Table 3. Effect sizes and between-study heterogeneity outcomes for nutritional deficiencies after OAGB and RYGB procedures.
N: number; OAGB: one-anastomosis gastric bypass; RYGB: Roux-en-Y gastric bypass
| Parameter | N of studies | N OAGB | N RYGB | Treatment Effect | Heterogeneity | |||
| OR (95%CI) | p | Model | I2(%) | ph | ||||
| Malnutrition | 4 | 3246 | 1609 | 3.00 (1.68 to 5.36) | < 0.0001 | F | 0 | 0.548 |
| Anemia | 9 | 2836 | 2504 | 1.38 (1.08 to 1.77) | 0.011 | F | 0 | 0.765 |
| Hypoalbuminemia | 8 | 1984 | 1978 | 2.38 (1.65 to 3.43) | < 0.0001 | F | 0 | 0.458 |
| Hypoproteinemia | 4 | 1160 | 527 | 1.85 (1.09 to 3.14) | 0.022 | F | 0 | 0.542 |
| Hypocalcemia | 4 | 284 | 214 | 1.78 (1.01 to 3.12) | 0.046 | F | 31.0 | 0.226 |
| Vitamin D deficiency | 4 | 282 | 208 | 1.29 (0.81 to 2.05) | 0.291 | F | 28.9 | 0.239 |
| Vitamin B12 deficiency | 4 | 252 | 194 | 1.13 (0.36 to 3.58) | 0.831 | R | 62.1 | 0.048 |
| Iron deficiency | 3 | 194 | 113 | 1.26 (0.68 to 2.32) | 0.464 | F | 0 | 0.844 |
| Ferritin deficiency | 3 | 196 | 126 | 1.05 (0.46 to 2.43) | 0.902 | R | 52.2 | 0.124 |
| Zinc deficiency | 2 | 403 | 144 | 1.00 (0.61 to 1.63) | 0.989 | F | 22.8 | 0.255 |
Subgroup Analysis
On subgroup analysis, we found that studies published in Asia showed significantly higher odds of anemia (OR = 1.41, 95%CI, 1.07 to 1.86, Figure 3A) and hypoalbuminemia (OR = 2.49, 95%CI, 1.70 to 3.65, Figure 3B) among patients who underwent OAGB compared to RYGB; these differences were not evident in the studies published in European countries. Subgroup analysis based on follow-up periods showed significantly higher proportions of anemia (OR = 1.42, 95%CI, 1.05 to 1.91, Figure 4A) and hypoalbuminemia (OR = 2.47, 95%CI, 1.63 to 3.75, Figure 4B) at ≥ 3 years but not at shorter follow-up periods. Additionally, the odds of anemia remained significantly higher after OAGB in studies that recruited >1500 patients (OR = 1.75, 95%CI, 1.17 to 2.62, Figure 6A), whereas medium-sized (OR = 2.44, 95%CI, 1.50 to 3.96) and large-sized studies (OR = 2.80, 95%CI, 1.37 to 5.69, Figure 6B) showed significantly higher proportions of hypoalbuminemia after OAGB. We could not perform a subgroup analysis based on the study design because only one study employed a randomized design [17].
Figure 3. Forest plots showing the results of subgroup analysis based on the study location to investigate the differences in the incidence of anemia (A) and hypoalbuminemia (B) after OAGB and RYGB procedures.
OAGB: one-anastomosis gastric bypass; RYGB: Reux-en-Y gastric bypass
Figure 4. Forest plots showing the results of subgroup analysis based on different follow-up periods to investigate the differences in the incidence of anemia (A) and hypoalbuminemia (B) after OAGB and RYGB procedures.
OAGB: one-anastomosis gastric bypass; RYGB: Reux-en-Y gastric bypass
Publication Bias
Publication bias was assessed for the outcomes with k > 5 studies. Results revealed that treatment effects were symmetrically distributed around the pooled estimate of anemia (Figure 5A) and hypoalbuminemia (Figure 5B). The outcomes of Egger’s test have also indicated no risk of publication bias (intercept = 0.09, p = 0.893 for anemia and intercept = -0.37, p = 0.612 for hypoalbuminemia).
Figure 5. Publication bias.
Discussion
Postoperative morbidity remains a significant challenge for bariatric surgeries. The malabsorptive effect of these surgeries may pose negative nutritional consequences. In the present meta-analysis, we found that OAGB procedures were associated with malnutrition and anemia, as well as deficiencies of blood albumin, total proteins, and calcium.
To the best of our knowledge, there are two published meta-analyses comparing OAGB and RYGB procedures [46,47]; those studies were primarily focused on procedural characteristics, as well as weight loss and metabolic outcomes. Although the previous meta-analyses showed that OAGB was associated with malnutrition, which is consistent with our meta-analysis, the authors did not investigate additional nutritional outcomes. With the inconsistent definition of malnutrition across the included studies, it was difficult to conclude reliable outcomes that could be further considered in the postoperative periods. Therefore, in the present study, we have heavily focused on specific parameters that could help investigate the potential sources of nutritional deficiencies to improve the standards of efficiency and safety of gastric bypass surgeries.
As with the aforementioned studies [46,47], we showed that patients in the OAGB arm could achieve better weight loss than RYGB. Although OAGB includes making a long sleeve tube and RYGB entails creating a small gastric pouch and small outlet, the gastric restriction effect is generally similar for both the procedure. Furthermore, the pattern of gut hormonal response is similar, where duodenal gut hormones and related enzymes are excluded by the duodenojejunal bypass, whereas a postprandial surge of distal gut hormones (glucagon-like peptide 1 (GLP-1) and peptide YY (PYY)) is observed in both procedures [48,49]. As such, weight-related differences can solely be explained by the variation in the bypass limb length. The standard biliopancreatic limbs (BPLs) in RYGB and OAGB surgeries are 50 and 200 cm, respectively. There is now accumulated evidence indicating that a longer BPL is associated with a better weight loss and more favorable glycemic control [50,51]; yet, better efficacy and safety profiles could be achieved for the effect of revision surgery at a threshold of < 70% of the small bowel [52].
Seemingly, BPL might have important roles in the observed nutritional deficiencies. For instance, Jammu et al, [38]. found that hypoalbuminemia was significantly more frequent among patients with a limb length of >230 cm, while only one case was reported among those with a 200 cm BPL. Mahawar et al. [53] have also suggested that a BPL of 150 cm is recommended in OAGB procedures to reduce the likelihood of severe protein-calorie malnutrition. Unfortunately, we could not assess the role of BPLs on the development of nutritional complications due to the lack of standardized lengths in the included studies (Table 1).
We believe technical modifications of gastric bypass procedures may also play a significant role in changing the risk profile of nutritional deficiencies, and this should be a matter of in-depth investigation to reach the standardized lengths of the small bowel bypassed that achieve maximum weight loss with minimum nutritional deficiencies.
Notably, other reasons may influence protein absorption in OAGB. Supposedly, hypoalbuminemia and hypoproteinemia are more pronounced in OAGB as a result of proximal jejunal bypass. Elgeidie et al. [54] proposed that protein-energy undernutrition may develop due to protein intolerance (an imbalance in bacterial flora, reduced pepsin production, and changes in gut hormones), steatorrhea (pancreatic proteolytic enzymes are deactivated in the acidic pH of the gastric pouch), postoperative incompliance to supplementation and ethnic variations. Interestingly, the effect of ethnicity on protein absorption was prominent in our study, with higher odds of hypoalbuminemia after OAGB in studies conducted on patients from Asia but not other continents. On the other hand, it has been previously shown that the absorption of meal protein-derived amino acids is accelerated after RYGB [55], which might partly explain the reported difference in our study.
Regarding other nutritional consequences, we found that OAGB was associated with hypocalcemia, and this might be related to the exclusion of a significant proportion of the proximal small bowel (the site of calcium absorption) [56]. The rates of anemia were significantly higher in the OAGB arm due to the reduced capacity to absorb iron. However, we could not find significant differences between OAGB and RYGB in the rates of iron deficiency; the small number of studies in such a comparison might have contributed to this finding.
Limitations
In the present study, there are several limitations that should be appraised. The reported outcomes were retrieved from retrospective studies and one open-label RCT. This might interfere with concluding reliable results and limit our understanding of the causal relationships between bariatric surgeries and nutritional complications. Also, given the lack of published studies in certain areas, such as the United States, we could not comprehensively assess postoperative complications across different ethnic groups. Finally, the small number of included studies might have impacted the results of some nutrients (iron, ferritin, and zinc) and for studies with long follow-up periods (≥3 years).
Conclusions
In conclusion, while OAGB surgery induced significantly higher weight loss than RYGB as indicated by %EWL and %TWL, OAGB procedures were associated with multiple nutritional deficiencies, including hypoalbuminemia, hypoproteinemia, and hypocalcemia. Additionally, higher proportions of anemia and malnutrition were observed after OAGB compared to RYGB. The results should be interpreted with caution given the inherent limitations of studies’ design (primarily retrospective investigations) and the small number of studies that assessed nutritional differences over long follow-up periods. Future large-sized RCTs are required to assess the efficacy and safety of OAGB on weight loss and nutritional outcomes, considering the roles of BPL length, ethnic variation, gut hormonal response, and the malabsorptive paradigm of gastric bypass surgeries.
Acknowledgments
Mohamed Tourky and Mohamed Issa shared the same effort and both should be acknowledged as the first authors of this work.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
Footnotes
The authors have declared that no competing interests exist.
References
- 1.World Health Organization: Obesity and overweight. [ Nov; 2021 ];https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight 2021
- 2.Obesity and severe obesity forecasts through 2030. Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, Dietz W. Am J Prev Med. 2012;42:563–570. doi: 10.1016/j.amepre.2011.10.026. [DOI] [PubMed] [Google Scholar]
- 3.Projected U.S. state-level prevalence of adult obesity and severe obesity. Ward ZJ, Bleich SN, Cradock AL, et al. N Engl J Med. 2019;381:2440–2450. doi: 10.1056/NEJMsa1909301. [DOI] [PubMed] [Google Scholar]
- 4.Treatment of obesity: weight loss and bariatric surgery. Wolfe BM, Kvach E, Eckel RH. Circ Res. 2016;118:1844–1855. doi: 10.1161/CIRCRESAHA.116.307591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus. Wu GZ, Cai B, Yu F, et al. Oncotarget. 2016;7:87511–87522. doi: 10.18632/oncotarget.11961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Weight outcomes of sleeve gastrectomy and gastric bypass compared to nonsurgical treatment. Arterburn DE, Johnson E, Coleman KJ, et al. Ann Surg. 2021;274:0–76. doi: 10.1097/SLA.0000000000003826. [DOI] [PubMed] [Google Scholar]
- 7.Gastric bypass in obesity. 1967. Mason EE, Ito C. Obes Res. 1996;4:316–319. doi: 10.1002/j.1550-8528.1996.tb00553.x. [DOI] [PubMed] [Google Scholar]
- 8.Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Wittgrove AC, Clark GW, Tremblay LJ. Obes Surg. 1994;4:353–357. doi: 10.1381/096089294765558331. [DOI] [PubMed] [Google Scholar]
- 9.Baseline data from American Society for Metabolic and Bariatric Surgery-designated bariatric surgery centers of excellence using the bariatric outcomes longitudinal database. DeMaria EJ, Pate V, Warthen M, Winegar DA. Surg Obes Relat Dis. 2010;6:347–355. doi: 10.1016/j.soard.2009.11.015. [DOI] [PubMed] [Google Scholar]
- 10.Reappraisal learning curve of laparoscopic Roux-en Y gastric bypass: retrospective results of one hundred and eight cases from a low-volume unit. Lo HC, Wu SM. BMC Surg. 2021;21:86. doi: 10.1186/s12893-021-01058-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.The mini-gastric bypass: experience with the first 1,274 cases. Rutledge R. Obes Surg. 2001;11:276–280. doi: 10.1381/096089201321336584. [DOI] [PubMed] [Google Scholar]
- 12.One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Carbajo M, García-Caballero M, Toledano M, Osorio D, García-Lanza C, Carmona JA. Obes Surg. 2005;15:398–404. doi: 10.1381/0960892053576677. [DOI] [PubMed] [Google Scholar]
- 13.Overview of gastric bypass surgery. Weledji EP. Int J Surg Open. 2016;5:11–19. [Google Scholar]
- 14.Gastric bypass - weight loss and metabolic outcomes similar with OAGB versus RYGB. Ray K. Nat Rev Gastroenterol Hepatol. 2019;16:262. doi: 10.1038/s41575-019-0142-x. [DOI] [PubMed] [Google Scholar]
- 15.Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy. Ivaska KK, Huovinen V, Soinio M, et al. Bone. 2017;95:47–54. doi: 10.1016/j.bone.2016.11.001. [DOI] [PubMed] [Google Scholar]
- 16.Bariatric surgery and long-term nutritional issues. Lupoli R, Lembo E, Saldalamacchia G, Avola CK, Angrisani L, Capaldo B. World J Diabetes. 2017;8:464–474. doi: 10.4239/wjd.v8.i11.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Robert M, Espalieu P, Pelascini E, et al. Lancet. 2019;393:1299–1309. doi: 10.1016/S0140-6736(19)30475-1. [DOI] [PubMed] [Google Scholar]
- 18.Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Lee WJ, Yu PJ, Wang W, Chen TC, Wei PL, Huang MT. Ann Surg. 2005;242:20–28. doi: 10.1097/01.sla.0000167762.46568.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG. BMJ. 2009;339:0. [PMC free article] [PubMed] [Google Scholar]
- 20.Higgins JP, Savović J, Page MJ, Elbers RG, Sterne JA. Cochrane Handbook for Systematic Reviews of Interventions, Version 6.2 [updated February 2021] London, UK: Cochrane; 2021. Assessing risk of bias in a randomized trial. [Google Scholar]
- 21.Wells GA, Shea B, O’Connell D, et al. Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford; [ Nov; 2021 ]. 2021. The Ottawa Hospital Research Institute: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [Google Scholar]
- 22.Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. Chichester, UK: John Wiley & Sons; 2019. [Google Scholar]
- 23.Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. Wan X, Wang W, Liu J, Tong T. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Early outcomes and mid-term safety of one anastomosis gastric bypass are comparable with Roux-en-Y gastric bypass: a single center experience. Kaplan U, Aboody-Nevo H, Gralnek IM, et al. Obes Surg. 2021;31:3786–3792. doi: 10.1007/s11695-021-05508-5. [DOI] [PubMed] [Google Scholar]
- 25.Utility of inflammatory markers in detection of perioperative morbidity after laparoscopic sleeve gastrectomy, laparoscopic Roux-en-Y gastric bypass, and one-anastomosis gastric bypass-multicenter study. Wysocki M, Małczak P, Wierdak M, et al. Obes Surg. 2020;30:2971–2979. doi: 10.1007/s11695-020-04636-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Comparative effectiveness of Roux-en-Y gastric bypass vs. one anastomosis gastric bypass on kidney function. Mahmoudieh M, Keleidari B, Hadipour P, Sheikhbahaei E, Chang AR, Ramtin S, Shahabi S. Obes Surg. 2021;31:2464–2470. doi: 10.1007/s11695-021-05295-z. [DOI] [PubMed] [Google Scholar]
- 27.Greater weight loss with the omega loop bypass compared to the Roux-en-Y gastric bypass: a comparative study. Disse E, Pasquer A, Espalieu P, Poncet G, Gouillat C, Robert M. Obes Surg. 2014;24:841–846. doi: 10.1007/s11695-014-1180-7. [DOI] [PubMed] [Google Scholar]
- 28.Complications after bariatric surgery: A multicentric study of 11,568 patients from Indian bariatric surgery outcomes reporting group. Goel R, Nasta AM, Goel M, et al. J Minim Access Surg. 2021;17:213–220. doi: 10.4103/jmas.JMAS_12_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities. Ruiz-Tovar J, Carbajo MA, Jimenez JM, Castro MJ, Gonzalez G, Ortiz-de-Solorzano J, Zubiaga L. Surg Endosc. 2019;33:401–410. doi: 10.1007/s00464-018-6307-9. [DOI] [PubMed] [Google Scholar]
- 30.Single-anastomosis sleeve jejunal bypass, a novel bariatric surgery, versus other familiar methods: results of a 6-month follow-up-a comparative study. Sayadishahraki M, Rezaei MT, Mahmoudieh M, Keleydari B, Shahabi S, Allami M. Obes Surg. 2020;30:769–776. doi: 10.1007/s11695-019-04266-9. [DOI] [PubMed] [Google Scholar]
- 31.Changes in serum albumin and liver enzymes following three different types of bariatric surgery: six-month follow-up. A retrospective cohort study. Zadeh MH, Zamaninour N, Ansar H, Kabir A, Pazouki A, Farsani GM. Sao Paulo Med J. 2021;139:598–606. doi: 10.1590/1516-3180.2021.00065.R1.1504221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Fasting and post-prandial peptide YY levels in obese patients before and after mini versus Roux-en-Y gastric bypass. Dardzińska JA, Kaska Ł, Wiśniewski P, Aleksandrowicz-Wrona E, Małgorzewicz S. Minerva Chir. 2017;72:24–30. doi: 10.23736/S0026-4733.16.07212-6. [DOI] [PubMed] [Google Scholar]
- 33.Efficacy comparison between 2 methods of laparoscopic gastric bypass surgery in the treatment of type 2 diabetes mellitus [Article in Chinese] Guo X, Yin K, Zhuo GZ, Chang XS, Ding D, Zheng CZ. https://pubmed.ncbi.nlm.nih.gov/23172521/ Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15:1125–1128. [PubMed] [Google Scholar]
- 34.15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures. Alkhalifah N, Lee WJ, Hai TC, Ser KH, Chen JC, Wu CC. Surg Endosc. 2018;32:3024–3031. doi: 10.1007/s00464-017-6011-1. [DOI] [PubMed] [Google Scholar]
- 35.Weight regain after bariatric surgery-a multicentre study of 9617 patients from indian bariatric surgery outcome reporting group. Baig SJ, Priya P, Mahawar KK, Shah S. Obes Surg. 2019;29:1583–1592. doi: 10.1007/s11695-019-03734-6. [DOI] [PubMed] [Google Scholar]
- 36.Comparison of one-anastomosis gastric bypass and Roux-en-Y gastric bypass for treatment of obesity: a 5-year study. Bhandari M, Nautiyal HK, Kosta S, Mathur W, Fobi M. Surg Obes Relat Dis. 2019;15:2038–2044. doi: 10.1016/j.soard.2019.05.025. [DOI] [PubMed] [Google Scholar]
- 37.Protein deficiency after gastric bypass: The role of common limb length in revision surgery. Chen JC, Shen CY, Lee WJ, Tsai PL, Lee YC. Surg Obes Relat Dis. 2019;15:441–446. doi: 10.1016/j.soard.2018.12.037. [DOI] [PubMed] [Google Scholar]
- 38.A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-en-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Jammu GS, Sharma R. Obes Surg. 2016;26:926–932. doi: 10.1007/s11695-015-1869-2. [DOI] [PubMed] [Google Scholar]
- 39.Comparing the efficacy and safety of Roux-en-Y gastric bypass with one-anastomosis gastric bypass with a biliopancreatic limb of 200 or 160 cm: 1-year results of the Tehran obesity treatment study (TOTS) Khalaj A, Mousapour P, Motamedi MA, Mahdavi M, Valizadeh M, Hosseinpanah F, Barzin M. Obes Surg. 2020;30:3528–3535. doi: 10.1007/s11695-020-04681-3. [DOI] [PubMed] [Google Scholar]
- 40.Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Lee WJ, Ser KH, Lee YC, Tsou JJ, Chen SC, Chen JC. Obes Surg. 2012;22:1827–1834. doi: 10.1007/s11695-012-0726-9. [DOI] [PubMed] [Google Scholar]
- 41.The prevalence of zinc deficiency in morbidly obese patients before and after different types of bariatric surgery. Soheilipour F, Ebrahimian M, Pishgahroudsari M, et al. BMC Endocr Disord. 2021;21:107. doi: 10.1186/s12902-021-00763-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Haematological indices and haematinic levels after mini gastric bypass: a matched comparison with Roux-en-Y gastric bypass. Madhok BM, Mahawar KK, Hadfield JN, Courtney M, Stubbing-Moore A, Koshy S, Small PK. Clin Obes. 2018;8:43–49. doi: 10.1111/cob.12227. [DOI] [PubMed] [Google Scholar]
- 43.One anastomosis gastric bypass-mini-gastric bypass (OAGB-MGB) versus Roux-en-Y gastric bypass (RYGB)-a mid-term cohort study with 612 patients. Rheinwalt KP, Plamper A, Rückbeil MV, Kroh A, Neumann UP, Ulmer TF. Obes Surg. 2020;30:1230–1240. doi: 10.1007/s11695-019-04250-3. [DOI] [PubMed] [Google Scholar]
- 44.Controlling nutritional status (CONUT) score and micronutrient deficiency in bariatric patients: midterm outcomes of Roux-en-Y gastric bypass versus one anastomosis gastric bypass/mini gastric bypass. Voglino C, Tirone A, Ciuoli C, et al. Obes Surg. 2021;31:3715–3726. doi: 10.1007/s11695-021-05486-8. [DOI] [PubMed] [Google Scholar]
- 45.Changes in anthropometric measures, nutritional indices and gastrointestinal symptoms following one anastomosis gastric bypass (OAGB) compared with Roux-en-y gastric bypass (RYGB) Zarshenas N, Tapsell LC, Batterham M, Neale EP, Talbot ML. Obes Surg. 2021;31:2619–2631. doi: 10.1007/s11695-021-05284-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Magouliotis DE, Tasiopoulou VS, Tzovaras G. Clin Obes. 2018;8:159–169. doi: 10.1111/cob.12246. [DOI] [PubMed] [Google Scholar]
- 47.One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: an updated meta-analysis. Magouliotis DE, Tasiopoulou VS, Tzovaras G. Obes Surg. 2019;29:2721–2730. doi: 10.1007/s11695-019-04005-0. [DOI] [PubMed] [Google Scholar]
- 48.The role of GLP-1 in the metabolic success of bariatric surgery. Hutch CR, Sandoval D. Endocrinology. 2017;158:4139–4151. doi: 10.1210/en.2017-00564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Lee WJ, Chen CY, Chong K, Lee YC, Chen SC, Lee SD. Surg Obes Relat Dis. 2011;7:683–690. doi: 10.1016/j.soard.2011.07.009. [DOI] [PubMed] [Google Scholar]
- 50.A longer biliopancreatic limb in Roux-en-Y gastric bypass improves weight loss in the first years after surgery: results of a randomized controlled trial. Homan J, Boerboom A, Aarts E, Dogan K, van Laarhoven C, Janssen I, Berends F. Obes Surg. 2018;28:3744–3755. doi: 10.1007/s11695-018-3421-7. [DOI] [PubMed] [Google Scholar]
- 51.A long biliopancreatic and short alimentary limb results in more weight loss in revisional RYGB surgery. Outcomes of the randomized controlled ELEGANCE REDO trial. Boerboom A, Homan J, Aarts E, Aufenacker T, Janssen I, Berends F. Surg Obes Relat Dis. 2019;15:60–69. doi: 10.1016/j.soard.2018.10.010. [DOI] [PubMed] [Google Scholar]
- 52.Distal small bowel bypass for weight regain after gastric bypass: safety and efficacy threshold occurs at <70% bypass. Caruana JA, Monte SV, Jacobs DM, Voytovich C, Ghanim H, Dandona P. Surg Obes Relat Dis. 2015;11:1248–1255. doi: 10.1016/j.soard.2015.08.001. [DOI] [PubMed] [Google Scholar]
- 53.Impact of biliopancreatic limb length on severe protein-calorie malnutrition requiring revisional surgery after one anastomosis (mini) gastric bypass. Mahawar KK, Parmar C, Carr WR, Jennings N, Schroeder N, Small PK. J Minim Access Surg. 2018;14:37–43. doi: 10.4103/jmas.JMAS_198_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Protein energy malnutrition after one-anastomosis gastric bypass with a biliopancreatic limb ≤200 cm: a case series. Elgeidie A, Abou El-Magd ES, Elghadban H, Abdelgawad M, Hamed H. J Laparoendosc Adv Surg Tech A. 2020;30:1320–1328. doi: 10.1089/lap.2020.0226. [DOI] [PubMed] [Google Scholar]
- 55.Accelerated protein digestion and amino acid absorption after Roux-en-Y gastric bypass. Bojsen-Møller KN, Jacobsen SH, Dirksen C, et al. Am J Clin Nutr. 2015;102:600–607. doi: 10.3945/ajcn.115.109298. [DOI] [PubMed] [Google Scholar]
- 56.Mechanisms of intestinal calcium absorption. Bronner F. J Cell Biochem. 2003;88:387–393. doi: 10.1002/jcb.10330. [DOI] [PubMed] [Google Scholar]





